Maria Inmaculada
Heras Fernando
Asociado Ciencias de la Salud
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublications in collaboration with researchers from Hospital Universitari de Tarragona Joan XXIII (7)
2020
-
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy
Leukemia, Vol. 34, Núm. 11, pp. 2925-2933
2015
-
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
Blood Cancer Journal, Vol. 5, pp. e352
-
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature
Oncotarget, Vol. 6, Núm. 31, pp. 31613-31627
2013
-
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
Leukemia, Vol. 27, Núm. 11, pp. 2157-2164
2011
-
Mortality risk factors in patients with zygomycosis: A retrospective and multicentre study of 25
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 4, pp. 263-268
2009
-
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy
Leukemia, Vol. 23, Núm. 3, pp. 486-491